Work

Phase II study of the effect of the topical corticosteroid fluocinonide in patients on endocrine therapy for breast cancer or breast cancer prevention with symptoms of vaginal dryness and dyspareunia.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.10105

Authors: Evthokia A. Hobbs, Kristine Lethert, Deirdre J. Nauman, Jenna Bucher, Emile Latour, Motomi Mori, Stephen Y. Chui, Kathleen A. Kemmer

Institutions: Oregon Health & Science University, Kaiser Permanente, Kaiser Permanente San Diego Medical Center, OHSU Knight Cancer Institute, Genentech

Language: English

Topic: Menopause: Health Impacts and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890836548

Cites:

Cited by:

Related to: 10